US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 2.450
  • -0.030-1.21%
Close May 14 16:00 ET
643.46MMarket Cap-11.67P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.08%-13.59M
-73.88%-40.66M
-93.50%-4.47M
6.59%-6.7M
-377.38%-10.07M
-10.80%-19.43M
68.03%-23.38M
95.78%-2.31M
-121.20%-7.17M
111.84%3.63M
Net income from continuing operations
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.20%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-139.40%-11.17M
Operating gains losses
-177.30%-327K
182.11%624K
--1.68M
--856K
---2.33M
--423K
-16.21%-760K
----
----
----
Depreciation and amortization
-96.65%314K
-0.33%37.5M
-0.63%9.35M
-0.35%9.37M
0.03%9.41M
-0.36%9.38M
-0.19%37.63M
-0.16%9.4M
-0.18%9.41M
-0.20%9.41M
Other non cash items
634.03%6.99M
1,059.57%17.44M
114.79%6.17M
1,961.48%7.78M
305.84%2.54M
238.79%952K
102.40%1.5M
103.78%2.87M
-102.86%-418K
45.15%-1.23M
Change In working capital
-96.25%-29.73M
-91.42%-39.68M
80.06%-3.23M
-82.00%-7.66M
-576.86%-13.64M
-376.92%-15.15M
-1,336.38%-20.73M
-200.28%-16.21M
-107.27%-4.21M
103.80%2.86M
-Change in receivables
-319.98%-27.87M
307.04%4.05M
81.59%-3.07M
20.36%-2.41M
-273.96%-3.15M
-41.21%12.67M
-91.20%994K
1.86%-16.7M
-105.14%-3.02M
94.97%-841K
-Change in inventory
-11.71%-4.95M
-1,017.27%-28.4M
27.88%-8.5M
65.72%-545K
-528.78%-14.93M
-160.35%-4.43M
-113.32%-2.54M
-148.18%-11.78M
-58.52%-1.59M
293.33%3.48M
-Change in prepaid assets
56.66%2.21M
-24.88%8.89M
16.26%2.09M
134.12%5.52M
-142.48%-130K
-80.86%1.41M
1,019.00%11.84M
120.55%1.8M
-74.46%2.36M
103.62%306K
-Change in payables and accrued expense
102.38%537K
7.36%-14.14M
-11.54%7.27M
-177.38%-6.16M
171.35%7.29M
33.94%-22.55M
58.18%-15.27M
235.39%8.22M
174.49%7.96M
110.61%2.69M
-Change in other current assets
108.81%54K
145.70%622K
-100.04%-3K
107.53%173K
134.76%1.07M
78.20%-613K
75.80%-1.36M
125.56%6.81M
-120.86%-2.3M
-145.63%-3.06M
-Change in other current liabilities
59.46%-945K
-0.38%-10.7M
77.72%-1.02M
44.27%-4.24M
-1,167.35%-3.11M
-290.44%-2.33M
-332.21%-10.65M
-125.83%-4.56M
-35.19%-7.61M
106.01%291K
-Change in other working capital
78.56%1.24M
----
----
----
----
118.59%695K
-180.32%-3.74M
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
30.08%-13.59M
-73.88%-40.66M
-93.50%-4.47M
6.59%-6.7M
-377.38%-10.07M
-10.80%-19.43M
68.03%-23.38M
95.78%-2.31M
-121.20%-7.17M
111.84%3.63M
Investing cash flow
Cash flow from continuing investing activities
154K
-33K
-2K
-2K
-29K
0
0
0
0
Net PPE purchase and sale
--154K
---33K
---2K
---2K
---29K
--0
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
--154K
---33K
---2K
---2K
---29K
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
305.64%74.94M
297.03%49.66M
1,830.62%22.33M
2,346.00%1.22M
195.50%7.64M
215.71%18.48M
-272.67%-25.21M
-128,900.00%-1.29M
100.15%50K
-88,788.89%-8M
Net issuance payments of debt
3,381.02%9.54M
124.69%7.9M
100.01%1K
--0
195.33%7.63M
101.71%274K
3.03%-32M
---8M
--0
---8M
Net common stock issuance
259.48%64.92M
509.11%41.38M
210.36%20.82M
3,390.00%1.75M
--750K
53,017.65%18.06M
-9.80%6.79M
671,000.00%6.71M
-20.63%50K
--0
Proceeds from stock option exercised by employees
241.84%482K
38,400.00%385K
22,900.00%230K
--0
--14K
--141K
-98.51%1K
--1K
--0
--0
Net other financing activities
----
----
----
---522K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
305.64%74.94M
297.03%49.66M
1,830.62%22.33M
2,346.00%1.22M
195.50%7.64M
215.71%18.48M
-272.67%-25.21M
-128,900.00%-1.29M
100.15%50K
-88,788.89%-8M
Net cash flow
Beginning cash position
20.12%53.55M
-52.15%44.58M
-25.91%35.69M
-25.55%41.17M
-26.89%43.62M
-52.15%44.58M
-38.64%93.17M
-67.41%48.18M
-62.38%55.29M
-66.41%59.67M
Current changes in cash
6,527.27%61.51M
118.46%8.97M
596.30%17.86M
23.09%-5.47M
43.83%-2.46M
97.14%-957K
17.18%-48.59M
93.42%-3.6M
-919.93%-7.12M
85.75%-4.37M
End cash Position
163.76%115.06M
20.12%53.55M
20.12%53.55M
-25.91%35.69M
-25.55%41.17M
-26.89%43.62M
-52.15%44.58M
-52.15%44.58M
-67.41%48.18M
-62.38%55.29M
Free cash flow
29.99%-13.61M
-74.02%-40.69M
-93.59%-4.47M
6.56%-6.7M
-378.18%-10.1M
-10.80%-19.43M
68.08%-23.38M
95.78%-2.31M
-121.20%-7.17M
111.84%3.63M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.08%-13.59M-73.88%-40.66M-93.50%-4.47M6.59%-6.7M-377.38%-10.07M-10.80%-19.43M68.03%-23.38M95.78%-2.31M-121.20%-7.17M111.84%3.63M
Net income from continuing operations 133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.20%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-139.40%-11.17M
Operating gains losses -177.30%-327K182.11%624K--1.68M--856K---2.33M--423K-16.21%-760K------------
Depreciation and amortization -96.65%314K-0.33%37.5M-0.63%9.35M-0.35%9.37M0.03%9.41M-0.36%9.38M-0.19%37.63M-0.16%9.4M-0.18%9.41M-0.20%9.41M
Other non cash items 634.03%6.99M1,059.57%17.44M114.79%6.17M1,961.48%7.78M305.84%2.54M238.79%952K102.40%1.5M103.78%2.87M-102.86%-418K45.15%-1.23M
Change In working capital -96.25%-29.73M-91.42%-39.68M80.06%-3.23M-82.00%-7.66M-576.86%-13.64M-376.92%-15.15M-1,336.38%-20.73M-200.28%-16.21M-107.27%-4.21M103.80%2.86M
-Change in receivables -319.98%-27.87M307.04%4.05M81.59%-3.07M20.36%-2.41M-273.96%-3.15M-41.21%12.67M-91.20%994K1.86%-16.7M-105.14%-3.02M94.97%-841K
-Change in inventory -11.71%-4.95M-1,017.27%-28.4M27.88%-8.5M65.72%-545K-528.78%-14.93M-160.35%-4.43M-113.32%-2.54M-148.18%-11.78M-58.52%-1.59M293.33%3.48M
-Change in prepaid assets 56.66%2.21M-24.88%8.89M16.26%2.09M134.12%5.52M-142.48%-130K-80.86%1.41M1,019.00%11.84M120.55%1.8M-74.46%2.36M103.62%306K
-Change in payables and accrued expense 102.38%537K7.36%-14.14M-11.54%7.27M-177.38%-6.16M171.35%7.29M33.94%-22.55M58.18%-15.27M235.39%8.22M174.49%7.96M110.61%2.69M
-Change in other current assets 108.81%54K145.70%622K-100.04%-3K107.53%173K134.76%1.07M78.20%-613K75.80%-1.36M125.56%6.81M-120.86%-2.3M-145.63%-3.06M
-Change in other current liabilities 59.46%-945K-0.38%-10.7M77.72%-1.02M44.27%-4.24M-1,167.35%-3.11M-290.44%-2.33M-332.21%-10.65M-125.83%-4.56M-35.19%-7.61M106.01%291K
-Change in other working capital 78.56%1.24M----------------118.59%695K-180.32%-3.74M--0--0--0
Cash from discontinued investing activities
Operating cash flow 30.08%-13.59M-73.88%-40.66M-93.50%-4.47M6.59%-6.7M-377.38%-10.07M-10.80%-19.43M68.03%-23.38M95.78%-2.31M-121.20%-7.17M111.84%3.63M
Investing cash flow
Cash flow from continuing investing activities 154K-33K-2K-2K-29K0000
Net PPE purchase and sale --154K---33K---2K---2K---29K--0--0--0--0----
Cash from discontinued investing activities
Investing cash flow --154K---33K---2K---2K---29K--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 305.64%74.94M297.03%49.66M1,830.62%22.33M2,346.00%1.22M195.50%7.64M215.71%18.48M-272.67%-25.21M-128,900.00%-1.29M100.15%50K-88,788.89%-8M
Net issuance payments of debt 3,381.02%9.54M124.69%7.9M100.01%1K--0195.33%7.63M101.71%274K3.03%-32M---8M--0---8M
Net common stock issuance 259.48%64.92M509.11%41.38M210.36%20.82M3,390.00%1.75M--750K53,017.65%18.06M-9.80%6.79M671,000.00%6.71M-20.63%50K--0
Proceeds from stock option exercised by employees 241.84%482K38,400.00%385K22,900.00%230K--0--14K--141K-98.51%1K--1K--0--0
Net other financing activities ---------------522K------------------------
Cash from discontinued financing activities
Financing cash flow 305.64%74.94M297.03%49.66M1,830.62%22.33M2,346.00%1.22M195.50%7.64M215.71%18.48M-272.67%-25.21M-128,900.00%-1.29M100.15%50K-88,788.89%-8M
Net cash flow
Beginning cash position 20.12%53.55M-52.15%44.58M-25.91%35.69M-25.55%41.17M-26.89%43.62M-52.15%44.58M-38.64%93.17M-67.41%48.18M-62.38%55.29M-66.41%59.67M
Current changes in cash 6,527.27%61.51M118.46%8.97M596.30%17.86M23.09%-5.47M43.83%-2.46M97.14%-957K17.18%-48.59M93.42%-3.6M-919.93%-7.12M85.75%-4.37M
End cash Position 163.76%115.06M20.12%53.55M20.12%53.55M-25.91%35.69M-25.55%41.17M-26.89%43.62M-52.15%44.58M-52.15%44.58M-67.41%48.18M-62.38%55.29M
Free cash flow 29.99%-13.61M-74.02%-40.69M-93.59%-4.47M6.56%-6.7M-378.18%-10.1M-10.80%-19.43M68.08%-23.38M95.78%-2.31M-121.20%-7.17M111.84%3.63M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Inverse ETF Inverse ETF
No. Symbol Turnover
Sample Name
Sample Code
 1.19B
Sample Name
Sample Code
 628.13M
Sample Name
Sample Code
 347.64M
4
ProShares UltraPro Short S&P500 ETF
SPXU
289.11M
5
Short Russell 2000 Proshares
RWM
278.86M
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Berkshire's 2025 Annual Shareholders Meeting

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 117.720
Sample Name
Sample Code
 135.340
Sample Name
Sample Code
 347.680
4
Alphabet-C
GOOG
166.810
5
Alphabet-A
GOOGL
165.370
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.4232
Sample Name
Sample Code
 2.100
Sample Name
Sample Code
 263.410
4
The9 Ltd
NCTY
12.000
5
FRMO CORP
FRMO
8.310
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -